Concepedia

James C. Kisicki

JC

Statistics

Publications

22

Citations

949

H-Index

17

Active since

1987

Affiliations

University of Nebraska–Lincoln(Current)

Celerion (Canada)

Johns Hopkins University

Celerion (United States)

Novartis (Switzerland)

James C. Kisicki is an author at University of Nebraska–Lincoln specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

1987–2011

22

Publications

22

Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution

Robert J. Przybelski, Elaine K. Daily, James C. Kisicki et al. · Critical Care Medicine · 1996 · 139 citations

, , +9

Oral Delivery of Anticoagulant Doses of Heparin

R Baughman, Shiv Kapoor, Rajesh Agarwal et al. · Circulation · 1998 · 129 citations

, , +17

Febuxostat (TMX‐67), a Novel, Non‐Purine, Selective Inhibitor of Xanthine Oxidase, Is Safe and Decreases Serum Urate in Healthy Volunteers

Michael A. Becker, James C. Kisicki, Reza Khosravan et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 96 citations

, , +17

Pramlintide: A Human Amylin Analogue Reduced Postprandial Plasma Glucose, Insulin, and C-peptide Concentrations in Patients with Type 2 Diabetes

R. Thompson, Alan Gottlieb, K. Organ et al. · Diabetic Medicine · 1997 · 71 citations

, , +15

Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin

S J Bannister, Vincent P. Houser, James D. Hulse et al. · Acta Psychiatrica Scandinavica · 1989 · 70 citations

, , +10

1–5 of 22